Vincristine Pfizer, Injektionslösung

7680536400524 CH-53640 Injektionslösung
Vincristine Pfizer, Injektionslösung
Vincristine Pfizer, Injektionslösung
Vincristine Pfizer, Injektionslösung
1 / 3
google

Article details

Package size
5 x 1 mg/1 mL
Selling units
5
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/12/2025
Summary of Product Characteristics
Français
06/12/2025
Summary of Product Characteristics
Italien
06/12/2025

Detailed composition

Substance Quantity Type Category
vincristini sulfas
1.0 MG Substance Wirkstoff (Principe actif)
mannitolum
- Substance HNIDK
acidum sulfuricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.0138 MG Substance HBESI

Reimbursement information

Public price
CHF 80.30
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 15/03/1997

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
53640
Drug name
Vincristine Pfizer, Injektionslösung
Galenic form
LSINJ
ATC Code
L01CA02
Authorization status
Z
Dispensing category
A
First authorization
10/09/1996
Authorization expiration date
30/09/2026
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
VINCRISTINE Pfizer 1 mg/ml 5 flac 1 ml
Description (DE)
VINCRISTINE Pfizer 1 mg/ml 5 Durchstf 1 ml
Market launch
10/09/1996
Narcotic (BTM)
No

Other package sizes (2)

VINCRISTINE Pfizer 2 mg/2ml 5 flac 2 ml
5 x 2 mg/2 mL DUR
GTIN: 7680536400609
View
None
None None
GTIN: None
Not in V1
Buy us a coffee Explore the data